You are here / Home / News
 

TSO3: First Quarter 2005 Financial Results

May 13, 2005

Québec City, May 13, 2005 – TSO3 Inc. (TSX: TOS) announced today its financial results for the first quarter of 2005. The Company recorded a net loss of $1,562,143 or $0.05 per share, for the first quarter of 2005, compared to a net loss of $1,542,004 or also $0.05 per share for the same period in 2004.

“The first quarter of 2005 was marked by the steps taken that are closely linked to the sale of our 125L Ozone Sterilizer”, stated Jocelyn Vézina, CEO at TSO3 Inc. “We are therefore showing in our financial statements for the first quarter of 2005, Deferred Revenues for units that are currently undergoing trial in North American hospitals. Our sales of Ozone Sterilizers will be announced and posted to our financial results in the event that the trial period has been completed and the transfer of property has been confirmed. In effect, the referral sites agreement assumes the acquisition of the sterilizer only once TSO3 has confirmation that expectations are fully met. We can expect our first sales in the second quarter of 2005”.


Summary of the activities for the quarter

In matters of activities closely related to commercialization, a notable step was the hiring of a new sales director for the United States market. He joins TSO3’s Vice President, Sales and Marketing, Ann Hewitt, in supporting the North American distributor, SKYTRON.

Furthermore, the teams at SKYTRON have undergone intensive training in early 2005, in preparation for participation of several of them in the Association of periOperative Registered Nurses (AORN) Congress – the most important trade show in the sterilization industry in the United States.

To view the analysis of the financial situation and the operating sesults, download the report for the first quarter.
© 2005-2008 TSO3. All Rights Reserved.